Induction of apoptosis and cell cycle arrest by a chalcone panduratin A isolated from Kaempferia pandurata in androgen-independent human prostate cancer cells PC3 and DU145

Carcinogenesis

Volumn 27, Issue 7, 2006, Pages 1454-1464

  Yun, Jung Mi ^a,b,c   Kweon, Mee Hyang ^c   Kwon, Hoonjeong ^b   Hwang, Jae Kwan ^a   Mukhtar, Hasan ^c  

^a Yonsei University   (South Korea)

^b Seoul National University   (South Korea)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CHALCONE DERIVATIVE; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; CYSTEINE PROTEINASE; FAS ANTIGEN; LIPOCORTIN 5; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PANDURATIN A; PROCASPASE 3; PROCASPASE 6; PROCASPASE 8; PROCASPASE 9; PROPIDIUM IODIDE; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ACINAR CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL METABOLISM; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEGRADATION; DRUG ISOLATION; DRUG MECHANISM; ENZYME INHIBITION; EVIDENCE BASED MEDICINE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC 50; IMMUNOBLOTTING; KAEMPFERA PANDURATA; MEDICINAL PLANT; MITOCHONDRION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN INDUCTION; STRUCTURE ACTIVITY RELATION; UPREGULATION;

ADENOCARCINOMA; ANDROGENS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; BCL-ASSOCIATED DEATH PROTEIN; BLOTTING, WESTERN; CASPASES; CELL CYCLE; CELL LINE, TUMOR; CHALCONES; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HUMANS; INHIBITORY CONCENTRATION 50; MALE; MEMBRANE GLYCOPROTEINS; PHYTOTHERAPY; PLANT EXTRACTS; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA; ZINGIBERACEAE;

EID: 33745601961     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi348     Document Type: Article

References (57)

1. Jemal,A., Murray,T., Ward,E., Samuels,A., Tiwari,R.C., Ghafoor,A., Feuer,E.J. and Thun,M.J. (2005) Cancer statistics, 2005. CA Cancer J. Clin., 55, 10-30.
2. Rini,B.I. and Small,E.J. (2002) Prostate cancer update. Curr. Opin. Oncol., 14, 286-291.
3. Tsao,A.S., Kim,E.S. and Hong,W.K. (2004) chemoprevention of cancer. CA Cancer J. Clin., 54, 150-180.
4. Jain,M.G., Hislop,G.T., Howe,G.R. and Ghadirian,P. (1999) Plant foods, antioxidants, and prostate cancer risk: Findings from case-control studies in Canada. Nutr. Cancer, 34, 173-184.
5. Trakoontivakorn,G., Nakahara,K., Shinmoto,H., Takenaka,M., Onishi-kameyama,M., Ono,H., Yoshida,M., Nagata,T. and Tsushida,T. (2001) Structural analysis of a novel antimutagenic compound, 4-hydroxypanduratin A, and antimutagenic activity of flavonoids in a Thai spice, fingerroot (Boesenbergia pandurata Schult.) against mutagenic heterocyclic amines. J. Agric. Food Chem., 49, 3046-3050.
6. Tuchinda,P., Reutrakul,V., Claeson,P., Ponprayoon,U., Sematong,T., Santosuk,T. and Taylor,W.C. (2002) Anti-inflammatory cyclohexenyl chalcone derivatives in Boesenberia pandurata. Phytochemistry, 59, 169-173.
7. Hsieh,H.K., Tsao,L.T., Wang,J.P. and Lin,C.N. (2000) Synthesis and anti-inflammatory effect of chalcones. J. Pharm. Pharmacol, 52, 163-171.
8. Yun,J.M., Kwon,H.J. and Hwang,J.K. (2003) In vitro anti-inflammatory activity of panduaratin A isolated from Kaempferia pandurata in RAW264.7 cells. Planta Medica, 69, 1102-1108.
9. Yun,J.M, Kwon,H., Mukhtar,H. and Hwang,J.K. (2005) Induction of apoptosis by panduratin A isolated from Kaempferia pandurata in human colon cancer HT-29 cells. Planta Medica, 71, 501-507.
10. Tuntiwachwutiikul,P., Pancharoen,O., Reutrakul,U. and Byrne,L.T. (1984) (1′RS, 2′SR,
11. Tubaro,A., Florio,C., Luxich,E., Vertua,R., Loggia,R.D. and Yasumoto,T. (1996) Suitability of the MTT-based cytotoxicity assay to detect okadaic acid contamination of mussels. Toxicon, 34, 965-974.
12. Jemal,A., Tiwari,R.C., Murray,T., Ghafoor,A., Samuels,A., Ward,E., Feuer,E.J. and Thun,M.J. (2004) American Cancer Society Cancer statistics, 2004. CA Cancer J. Clin., 54, 8-29.
13. Dragsted,L.O., Strube,M. and Larsen,J.C. (1993) Cancer-protective factors in fruits and vegetables: Biochemical and biological background. Pharmacol. Toxicol, 72, 116-135.
14. Tavani,A. and La Vecchia,C. (1995) Fruit and vegetable consumption and cancer risk in a Mediterranean population. Am. J. Clin. Nut., 61, 1374S-1377S.
15. Singh,R.P., Dhanakakshmi,S. and Agarwal,R. (2002) Phytochemicals as cell cycle modulators: A less toxic approach in halting human cancer. Cell Cycle, 1, 156-161.
16. Hu,W. and Kavanagh,J.J. (2003) Anticancer theraphy targeting the apoptotic pathway. Lancet Oncol., 4, 721-729.
17. Ahmad,N., Feyes,D.K., Nieminen,A.L., Agarwal,R. and Mukhtar,H. (1997) Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J. Natl. Cancer Inst., 89, 1881-1886.
18. Lee,E. and Surh,Y.J. (1998) Induction of apoptosis in HL-60 cells by pungent vanilloids, [6]-gingerol and [6]-paradol. Cancer Lett, 134, 163-168.
19. Taraphdar,A.K., Roy,M. and Bhattacharya,R.K. (2001) Natural products as inducers of apoptosis: Implication for cancer theraphy and prevention. Curr. Sci., 80, 1387-1396.
20. Utz,P.J. and Anderson,P. (2000) Life and death decisions: Regulation of apoptosis by prteolysis of signaling molecules. Cell Death Differ., 7, 589-602.
21. Saraste,A. and Pulkki,K. (2000) Morphologic and biochemical hallmark of apoptosis. Cardiovasc. Res., 45, 528-537.
22. Solary,E., Droin,N. and Sordet,O. (2002) Cell death pathways as targets for anticancer drugs. In: Baguley,B.C. and Kerr,D.J. (eds) Anticancer Drug Development. Academic Press, San Diego, CA, pp. 55-76.
23. Utz,P.J. and Anderson,P. (2000) Life and death decisions: Regulation of apoptosis by prteolysis of signaling molecules. Cell Death Differ., 7, 589-602.
24. Li,P., Nijhawan,D., Budihardjo,I., Srinivasula,S.M., Ahmad,M., Alnermri,E.S. and Wang,X. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 91, 479-489.
25. Fulda,S., Meyer,E., Friesen,C., Susin,S.A., Kroemer,G. and Debatin,K.M. (2001) Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis. Oncogene, 20, 1063-1075.
26. Shi,Y.A. (2001) structural view of mitochondria-mediated apoptosis. Nat. Struct. Biol., 8, 394-401.
27. Thornberry,N. and Lazebnik,Y. (1998) Caspases: Ememies within. Science, 281, 1312-1316.
28. Ashkenazi,A. and Dixit,V.M. (1998) Death receptors: Signaling and modulation. Science, 281, 1305-1308.
29. Chinnaiyan,A.M., O'Rourke,K., Tewari,M. and Dixit,V.M. (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell, 81, 505-512.
30. Peter,M.E. and Krammer,P.H. (1998) Mechanisms of CD95 (APO-1/ Fas)-mediated apoptosis. Curr. Opin. Immunol., 10, 545-551.
31. Pepper,C., Hoy,T. and Bently,D.P. (1997) Bcl-2/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro apoptosis and clinical resistance. Br. J. Cancer, 76, 935-938.
32. Griffith,T.S., Anderson,R.D., Davidson,B.L., Williams,R.D. and Ratliff,T.L. (2000) Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis. J. Immunol., 165, 2886-2894.
33. Van Ophoven,A., Ng,C.P., Patel,B., Bonavida,B. and Belldegrun,A. (1999) Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) for treatment of prostate cancer: First results and review of literature. Protate Cancer Prostatic Dis., 2, 227-233.
34. Krammer,P.H. (2000) CD95's deadly mission in the immune system. Nature, 407, 789-795.
35. Walczak,H. and Krammer,P.H. (2000) The CD95(APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp. Cell Res., 256, 58-66.
36. Eakes,R., Desagher,S., Antonsson,B. and Martinou,J.C. (2000) Bid induces the oligomerization and insertion of Bax into the outer mitochondria membrane. Mol. Cell. Biol., 20, 929-935.
37. Korsmeyer,S.J, Wei,M.C., Saito,M., Weiler,S., Oh,K.J. and Schlesinger,P.H. (2000) Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ., 7, 1166-1173.
38. Yin,X.M. (2000) Signal transduction mediated by Bid, a pro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathways. Cell Res., 10, 161-167.
39. Muller,M., Strand,S. and Hug,H. (1997) Drug-induced apoptosis in hepatoma cells is mediated by the CD95(APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J. Clin. Invest., 99, 403-413.
40. Petak,I. and Houghton,J.A. (2001) Shared pathways: Death receptors and cytotoxic drugs in cancer therapy. Pathol. Oncol. Res., 7, 95-106.
41. Fu,Y., Hsieh,T.C., Guo,J., Kunichi,J., Lee,M.Y., Darzynkiewicz,Z. and Wu,J.M. (2004) Licochalcone-A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra), causes G2 and late-G1 arrests in androgen-independent PC3 prostate cancer cells. Biochem. Biophys. Res. Commun., 322, 263-270.
42. King,R.W., Jackson,P.K. and Kirshner,M.W. (1994) Mitosis in transition, Cell, 79, 563-571.
43. 2/M transitions of the cell cycle: identification of major phosphorylaiton sites. EMBO J., 10, 305-316.
44. Ferrell,J.E., Wu,M., Gerhart,J.C and Martin,G.S. (1999) Cell cycle tyrosine phosphorylation of p34 cdc2 and a microgubule-associated protein kinase homolog in Xenopus oocytes nad eggs. Mol. Cell. Biol., 11, 1965-1971.
45. Graves,P.R., Yu,L., Schwarz,J.K., Gales,J., Sausville,E.A., O'Connor,P.M. and Piwnica-Worms,H. (2000) The chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01. J. Biol. Chem., 275, 5600-5605.
46. 2/M transition by p53. Oncogene., 20, 1803-1815.
47. Lowe,S.W. and Lin,A.W. (2000) Apoptotiss in cancer. Carcinogenesis(Lond.), 21, 485-495.
48. DiPaola,R.S., Patel,J and Rafi,M.M. (2001) Targeting apoptosis in prostate cancer. Hematol. Oncol. Clin. North Am., 15, 509-524.
49. Castedo,M., Perfettini,J.L., Roumier,T. and Kroemer,G. (2002) Cyclin-dependent kinase-1:lInking apoptosis to cell cycle and mitotic catastrophe. Cell Death Differ., 9, 1287-1293.
50. Bates,S. and Vousden,K.H. (999) Mechanisms of p53-mediated apoptosis. Cell. Mol. Life Sci., 55, 28-37.
51. Xing,Y., Hannon,G., Zhang,H., Kobayashi,R. and Beach,D. (1993) p21 a universal inhibitor of cyclin kinases. Nature, 366, 701-704.
52. 2/M arrest. J. Biol. Chem., 271, 29556-29560.
53. 2/M-phase transition. Mol. Cell. Biol., 18, 546-557.
54. Polyak,K., Kato,J.Y., Solomon,M.J., Sherr,C.J., Massague,J., Roberts,J.M. and Koff,A. (1994) p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev., 8, 9-22.
55. Slingerland,J.M., Hengst,L., Pan,C.H., Alexander,D., Stampfer,M.R. and Reed,S.I. (1994) A novel inhibitor cyclin-Cdk activity detected in transforming growth factor beta-arrest epithelial cells. Mol. Cell. Biol., 14, 3683-3694.
56. 1 cyclin-dependent kinases,. Genes Dev., 9, 1149-1163.
57. Lee,M.H. and Yang,H.Y. (2001) Negative regulators of cyclin-dependent kinases and their roles in cancers. Cell. Mol. Life Sci., 58, 1907-1922.